Stay updated on Savolitinib for MET Amplified Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Savolitinib for MET Amplified Colorectal Cancer Clinical Trial page.

Latest updates to the Savolitinib for MET Amplified Colorectal Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe record displays details of the savolitinib study, including its terminated status, eligibility criteria, study design and outcomes, locations, and supporting documents.SummaryDifference68%

- Check14 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0 while the page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA site-wide banner announces updates and FAQs about NIH website changes, including a notice about terminology shifting from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check28 days agoChange DetectedThe footer’s site revision label changes from v3.7.1 to v3.7.2 while the page continues to show a 403 error.SummaryDifference0.2%

- Check35 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page now displays a 403 Forbidden error, signaling restricted access to the study record. The header shows a minimal navigation with a Home link and a revision note, replacing the previously accessible study content.SummaryDifference19%

Stay in the know with updates to Savolitinib for MET Amplified Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Savolitinib for MET Amplified Colorectal Cancer Clinical Trial page.